Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy.

  • Galán, Miguel
  • Fernández-Méndez, Laura
  • Núñez, Vanessa
  • Femenía-Muiña, Marcos
  • Figuera-Belmonte, Pau
  • Moya-Ruiz, Elena
  • Martínez-Cano, Sarai
  • Hernández-García, Elena
  • Rodrigo-Tapias, Manuel
  • Rodríguez-Ronchel, Ana
  • Relaño-Rupérez, Carlos
  • Wculek, Stefanie K
  • Benguria, Alberto
  • Dopazo, Ana
  • Henri, Sandrine
  • Jo, Suin
  • Liu, Tian-Tian
  • Malissen, Bernard
  • Murphy, Kenneth M
  • Ramiro, Almudena R
  • Carregal-Romero, Susana
  • Ruiz-Cabello, Jesús
  • Robles-Vera, Iñaki
  • Sancho, David
Atherosclerosis is characterized by immune cell accumulation in the arterial wall and adaptive CD4 T helper 1 immunity contributes to atherosclerosis development. However, how conventional dendritic cells (DCs) orchestrate this adaptive response remains controversial. This study unveils strategies for the gain and loss of function of cDCs to decipher their role in atherosclerosis induction in relation to adaptive T-cell immunity. We tested atherosclerosis in mice fed a high-cholesterol diet (HCD). Expansion of DCs in vivo was achieved by overexpression of FLT3L (Fms-like tyrosine kinase 3 ligand), while the effect of ablation of conventional type 1 DCs (cDC1s) in atherosclerosis was analyzed by grafting bone marrow from different mouse models of cDC1 depletion, including and Δ32 mice, into lethally irradiated recipients before HCD. CD3 T-cell subsets were analyzed using flow cytometry or single-cell RNA sequencing (scRNA-seq). Nanoparticles loaded with dexamethasone and decorated with anti-CLEC9A antibody to target cDC1s were tested for immunotherapy. Expansion of DCs in mice fed HCD for 8 weeks led to increased atherosclerotic lesion, which was prevented when mice were grafted before DC expansion with cDC1-depleted bone marrow compared with controls. Consistently, even in the absence of DC expansion, cDC1 deficiency prevented HCD-induced atherosclerosis. The scRNA-seq analysis of aortic CD3 T cells in this experimental approach showed a local reduction in CD4 Th1 and CD8 IFN (interferon)-γ T cells in the absence of cDC1s compared with control mice. Mechanistically, stimulator of IFN genes (STING) in cDC1s was required for the proatherogenic function of cDC1s. As a potential cDC1-targeted immunotherapy for atherosclerosis, we generated lipid nanoparticles decorated with an anti-CLEC9A antibody to specifically target cDC1s. When loaded with the immunosuppressive drug dexamethasone, these nanoparticles promoted a reduction of the atherosclerotic lesion in mice fed HCD, correlating with decreased CD4 Th1 and CD8 IFN-γ T cells in the spleen. These immunosuppressive nanoparticles, however, did not impair antiviral response. Using state-of-the-art strategies, our results establish that cDC1s have a proatherogenic role in atherosclerosis by boosting CD4 and CD8 T-cell immunity and propose that cDC1s can be targeted with an immunosuppressive drug to decrease atherosclerosis progression.
Repisalud
Publicación Artículo científico (JournalArticle)

pDCs amplify tissue-resident memory CD8+ T cell responses during viral reinfection.

  • Hernández-García, Elena
  • Galán, Miguel
  • Khouili, Sofía C
  • Moya-Ruiz, Elena
  • Redondo-Urzainqui, Ana
  • Cueto, Francisco J
  • Martínez-Cano, Saraí
  • Rodrigo-Tapias, Manuel
  • Tomasello, Elena
  • Mañes, Santos
  • Dalod, Marc
  • Sancho, David
  • Iborra, Salvador
Resident memory CD8+ T cells (Trms) are essential for protecting barrier nonlymphoid tissues (NLTs) against reinfection, yet the involvement of dendritic cells (DCs) in this process and the nature of Trm-DC interactions within these tissues remain poorly understood. Our study demonstrates that upon reactivation, memory CD8+ T cells located in the skin-independently of circulating memory counterparts-initiate the infiltration and maturation of plasmacytoid DCs (pDCs) in the tissue. This, in turn, promotes the maturation of conventional type 1 DCs (cDC1s) through type I IFN (IFN-I) signaling in a pDC-dependent manner. Depletion of pDCs or blocking IFN-I signaling disrupts this axis, severely impairing Trm-driven protection against secondary infections with vaccinia virus (VACV) in the skin. Notably, this pDC-dependent, IFN-I-mediated pathway is also essential for Trm-mediated protection against secondary respiratory infections with influenza A virus (IAV). Our findings uncover a crucial collaboration between Trm, pDCs, and cDC1s, offering new insights for enhancing vaccines.
Repisalud
Publicación Artículo científico (JournalArticle)

Dendritic cells as orchestrators of anticancer immunity and immunotherapy.

  • Heras-Murillo, Ignacio
  • Adán-Barrientos, Irene
  • Galán, Miguel
  • Wculek, Stefanie K
  • Sancho, David
Dendritic cells (DCs) are a heterogeneous group of antigen-presenting innate immune cells that regulate adaptive immunity, including against cancer. Therefore, understanding the precise activities of DCs in tumours and patients with cancer is important. The classification of DC subsets has historically been based on ontogeny; however, single-cell analyses are now additionally revealing a diversity of functional states of DCs in cancer. DCs can promote the activation of potent antitumour T cells and immune responses via numerous mechanisms, although they can also be hijacked by tumour-mediated factors to contribute to immune tolerance and cancer progression. Consequently, DC activities are often key determinants of the efficacy of immunotherapies, including immune-checkpoint inhibitors. Potentiating the antitumour functions of DCs or using them as tools to orchestrate short-term and long-term anticancer immunity has immense but as-yet underexploited therapeutic potential. In this Review, we outline the nature and emerging complexity of DC states as well as their functions in regulating adaptive immunity across different cancer types. We also describe how DCs are required for the success of current immunotherapies and explore the inherent potential of targeting DCs for cancer therapy. We focus on novel insights on DCs derived from patients with different cancers, single-cell studies of DCs and their relevance to therapeutic strategies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Investigating intracellular persistence of Staphylococcus aureus within a murine alveolar macrophage cell line

  • Lacoma, Alicia|||0000-0002-2049-3872
  • Cano, Victoria|||0000-0002-2537-4063
  • Moranta, D.|||0000-0001-9528-4920
  • Regueiro, Verónica
  • Domínguez Villanueva, Dídac
  • Laabei, Maisem|||0000-0002-8425-3704
  • González-Nicolau, M.
  • Ausina, Vicente|||0000-0002-1798-9869
  • Prat, C.
  • Bengoechea, J. A.
Objective : Staphylococcus aureus is a particularly difficult pathogen to eradicate from the respiratory tract. Previous studies have highlighted the intracellular capacity of S.aureus in several phagocytic and non-phagocytic cells. The aim of this study was to define S.aureus interaction within a murine alveolar macrophage cell line. Methods : Cell line MH-S was infected with Newman strain. Molecular mechanisms involved in phagocytosis were explored. To assess whether S.aureus survives intracellularly quantitative (gentamicin protection assays and bacterial plating) and qualitative analysis (immunofluorescence microscopy) were performed. Bacterial colocalization with different markers of the endocytic pathway was examined to characterize its intracellular trafficking. Results : We found that S.aureus uptake requires host actin polymerization, microtubule assembly and activation of phosphatidylinositol 3-kinase signaling. Time course experiments showed that Newman strain was able to persist within macrophages at least until 28.5 h post infection. We observed that intracellular bacteria are located inside an acidic subcellular compartment, which co-localizes with the late endosome/lysosome markers Lamp-1, Rab7 and RILP. Colocalization counts with TMR-dextran might reflect a balance between bacterial killing and intracellular survival. Conclusions : This study indicates that S.aureus persists and replicates inside murine alveolar macrophages, representing a privileged niche that can potentially offer protection from antimicrobial activity and immunological host defense mechanisms.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Accessory gene regulator (Agr) functionality in Staphylococcus aureus derived from lower respiratory tract infections

  • Gomes Fernandes, Meissiner|||0000-0002-9454-8848
  • Laabei, Maisem|||0000-0002-8425-3704
  • Pagan Maldonado, Natalia|||0000-0002-3379-3903
  • Hidalgo, Jessica
  • Molinos Abos, Sonia|||0000-0001-8797-1368
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Domínguez Villanueva, Dídac
  • Jenkins, Andrew Toby A.|||0000-0002-8981-3029
  • Lacoma, Alicia|||0000-0002-2049-3872
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
Objective. Characterization of Staphylococcus aureus clinical isolates derived from lower respiratory tract infections (LRTIs), and correlation between the functionality of the accessory gene regulator (Agr) and genotypic and phenotypic characteristics, clinical variables and clinical outcome. Methods. S aureus isolates derived from LRTIs and control groups (nasal carriage and bacteraemia) were genotyped using StaphyType DNA microarray. Agr activity was evaluated using the CAMP synergistic haemolysis assay and the Vesicle Lysis Test (VLT). Discordant strains were analysed by quantitative reverse- transcriptase real-time PCR (qRT-PCR). Results. Agr was functional in 79.7% and 84.5% of strains according to the CAMP and VLT assays respectively. Higher concordance with RNAIII expression measured by qRT-PCR was observed with the VLT assay (76.2%) compared with the CAMP assay (23.8%). No statistically significant differences were observed in Agr functionality between the study groups, nor the phenotypical/genotypical bacterial characteristics. No association between increased mortality/respiratory complications and Agr function was observed. Conclusions. Agr activity was high (82.2%) in isolates from LRTIs suggesting the importance of this global regulator in lower respiratory tract colonisation and infection. However, equally high Agr activity was observed in isolates derived from nasal carriage and bacteraemia, contradictory to previous observations. Agr functionality measured by the VLT assay was superior to CAMP assay.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cigarette smoke exposure redirects Staphylococcus aureus to a virulence profile associated with persistent infection

  • Lacoma, Alicia|||0000-0002-2049-3872
  • Edwards, A. M.|||0000-0002-7173-7355
  • Young, Bernadette|||0000-0001-6071-6770
  • Domínguez, José|||0000-0001-7888-0309
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Laabei, Maisem|||0000-0002-8425-3704
Tobacco smoking represents the leading preventable cause of death worldwide. Smoking is a recognised risk factor for several pathologies and is detrimental to host immune surveillance and defence. However, the impact of smoking on microbial residents of the nasopharyngeal cavity, in contact with cigarette smoke (CS), is lacking. Staphylococcus aureus is a major human pathogen that colonises the human nasopharynx and causes a wide range of infections. We investigated the impact of CS on specific virulence phenotypes important in S aureus pathogenesis. We observed strain-dependent differences following exposure to CS, namely growth inhibition, augmented biofilm formation, increased invasion of, and persistence within, bronchial alveolar epithelial cells. Additionally, we confirm the critical role of a functional accessory gene regulator (Agr) system in mediating increased biofilm development and host cell invasion and persistence following CS exposure. Furthermore, CS exposure resulted in reduced toxin production. Importantly, exposure of S aureus to CS accelerated the frequency of mutations and resulted in a significant increase in gentamicin-resistant small colony variant (SCV) formation. Mutational analysis revealed that CS induced SCVs emerge via the SOS response DNA mutagenic repair system. Taken together, our results suggest that CS redirects certain S aureus strains to a virulence profile associated with persistence.